Početna stranicaPTKFY • OTCMKTS
add
PT Kalbe Farma Unsponsored Indonesia ADR
Preth. zaklj. cijena
17,72 $
Godišnji raspon
11,44 $ - 23,73 $
Tržišna kapitalizacija
65,54 bil. IDR
Prosječna količina
20,00
P/E omjer
-
Prinos dividende
-
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (IDR) | lip 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 8,23 bil. | 3,37 % |
Operativni troškovi | 2,24 bil. | 10,65 % |
Neto dohodak | 898,17 mlr. | 5,97 % |
Neto profitabilnost | 10,91 | 2,54 % |
Zarada po dionici | 19,78 | 8,50 % |
EBITDA | 1,26 bil. | 0,42 % |
Efektivna porezna stopa | 23,09 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (IDR) | lip 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 3,95 bil. | 2,69 % |
Ukupna imovina | 29,51 bil. | 3,30 % |
Ukupne obveze | 5,32 bil. | 5,83 % |
Ukupni kapital | 24,19 bil. | — |
Dionice u optjecaju | 45,39 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,04 | — |
Povrat imovine | 8,82 % | — |
Povrat kapitala | 10,42 % | — |
Tok novca
Neto promjena novca
| (IDR) | lip 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 898,17 mlr. | 5,97 % |
Gotovina od poslovanja | 956,75 mlr. | −17,88 % |
Gotovina iz ulaganja | 117,04 mlr. | 123,27 % |
Gotovina iz financiranja | −1,78 bil. | −47,25 % |
Neto promjena novca | −740,01 mlr. | −90,86 % |
Slobodan tok novca | 667,76 mlr. | 18,23 % |
Više
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Osnovano
10. ruj 1966.
Web-lokacija
Zaposlenici
12.832
